Naltrexone
FDA status: FDA has approved products that contain naltrexone, including Contrave Extended-Release, Vivitrol.
PubMed: 8,940 publications mention Naltrexone, 1,217 of them trials or reviews. Search PubMed
- Pharmacotherapy for Alcohol Use Disorder: A Systematic Review and Meta-Analysis. McPheeters M et al. JAMA, 2023. Meta-Analysis, Systematic Review. PMID 37934220 · DOI
- A systematic review and meta-analysis of the efficacy and safety of pharmacological treatments for obesity in adults. McGowan B et al. Nature medicine, 2025. Systematic Review, Network Meta-Analysis. PMID 41039116 · DOI
- Low-Dose Naltrexone for Chronic Pain: Update and Systemic Review. Kim PS et al. Current pain and headache reports, 2020. Systematic Review. PMID 32845365 · DOI
- Pharmacotherapies for Adults With Alcohol Use Disorders: A Systematic Review and Network Meta-analysis. Bahji A et al. Journal of addiction medicine, 2022. Systematic Review, Network Meta-Analysis. PMID 35653782 · DOI
- Combined Pharmacotherapy and Cognitive Behavioral Therapy for Adults With Alcohol or Substance Use Disorders: A Systematic Review and Meta-analysis. Ray LA et al. JAMA network open, 2020. Meta-Analysis, Systematic Review. PMID 32558914 · DOI
ClinicalTrials.gov: 537 registered studies. See all studies
- NCT05037032 Effects of Naltrexone on Nocturnal Breathing Patterns at Altitude (Phase 4), completed
- NCT05228418 Bridging ED to Outpatient AUD Therapy With Naltrexone (Phase 4), unknown
MedlinePlus drug information ↗FDA label (DailyMed) ↗RxNorm 7243 ↗PubChem CID 5360515 ↗Wikipedia ↗









